Compound for regulating and controlling 15-PGDH activity and preparation method therefor
By providing a new compound, using its specific structural characteristics to react with the 15-PGDH enzyme, the need to regulate 15-PGDH activity is solved, effective inhibition of 15-PGDH enzyme and upregulation of PGE2 activity is achieved, and treatment is achieved. The potential of fibrosis and inflammatory diseases.
Patent Information
- Application Number
- PCT/CN2024/093993
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-19
- Filing Date
- 2024-05-17
- Publication Date
- 2024-11-28
AI Technical Summary
Existing 15-PGDH inhibitors and agonists have limitations in the treatment of related diseases, especially in the lack of effective small-molecule compounds in the regulation of 15-PGDH activity.
A novel compound with specific structural characteristics is provided, which can act as an inhibitor of 15-PGDH, regulate its activity by reacting with 15-PGDH enzyme, and can upregulate the activity of PGE2 in vivo. The structure of the compound includes aromatic rings, aromatic heterocycles, unsaturated lipid heterocycles, etc., and is prepared by a specific chemical reaction synthesis method.
This compound can effectively inhibit the activity of 15-PGDH enzyme, significantly increase the IC50 value, and upregulate the activity of PGE2 in cells, and has potential effects on the treatment of fibrosis, inflammatory diseases and other diseases related to 15-PGDH.
Smart Images

Figure CN2024093993_28112024_PF_FP_ABST
Abstract
Citation Information
Patent Citations
Compositions and methods of modulating short-chain dehydrogenase activity
CN108012528A
Compositions and methods of modulating short-chain dehydrogenase activity
CN110573154A
15-PGDH inhibitor
CN113226310A
Heterocyclic inhibitors of histamine receptors for the treatment of disease
WO2011112731A2
15-PGDH inhibitors
WO2020160151A1
